BRIEF published on 04/02/2025 at 19:10, 8 months 2 days ago HUBER+SUHNER AG Shareholders Approve Board Proposals in AGM Shareholder Approval Dividend Distribution HUBER+SUHNER Board Proposals AGM 2025
PRESS RELEASE published on 04/02/2025 at 19:05, 8 months 2 days ago Annual General Meeting of HUBER+SUHNER AG: Shareholders endorse all of the Board of Directors’ proposals HUBER+SUHNER AG's Annual General Meeting: Shareholders endorse all Board proposals, including dividend distribution and board member confirmations Annual General Meeting Shareholders HUBER+SUHNER AG Dividend Distribution Board Proposals
BRIEF published on 03/11/2025 at 06:50, 8 months 24 days ago HUBER+SUHNER Reports Sales and Profit Increase for 2024 Order Intake HUBER+SUHNER EBIT Growth 2024 Financial Results Communication Segment
PRESS RELEASE published on 03/11/2025 at 06:45, 8 months 24 days ago HUBER+SUHNER increases sales and profit in 2024 HUBER+SUHNER AG increases sales and profit in 2024 with solid net sales and order growth, higher dividend proposed. Communication segment drives profitability Sales Net Sales HUBER+SUHNER AG Profit Order Growth Communication Segment
BRIEF published on 02/10/2025 at 06:50, 9 months 22 days ago HUBER+SUHNER Emission Targets Validated by SBTi Sustainability GHG Reduction Climate Strategy Net-zero Trajectory Emission Targets
PRESS RELEASE published on 02/10/2025 at 06:45, 9 months 22 days ago HUBER+SUHNER receives validation of its greenhouse gas emissions reduction targets by SBTi HUBER+SUHNER receives validation of its greenhouse gas emissions reduction targets by SBTi, setting trajectory towards net-zero. Commitment to sustainability integral to strategy Sustainability Greenhouse Gas Emissions SBTi HUBER+SUHNER Validation
BRIEF published on 01/23/2025 at 06:50, 10 months 12 days ago HUBER+SUHNER Sees Growth in 2024 Sales and Order Intake Transportation Segment HUBER+SUHNER 2024 Financial Results Order Intake Growth Communication Segment
PRESS RELEASE published on 01/23/2025 at 06:45, 10 months 12 days ago HUBER+SUHNER increases order intake and sales in 2024 HUBER+SUHNER reports increased order intake and sales in 2024, with solid growth mainly driven by the Communication segment and Industry segment's aerospace and defense growth initiative Order Intake Sales Increase HUBER+SUHNER Industry Segment Communication Segment
BRIEF published on 10/22/2024 at 06:50, 1 year 1 month ago HUBER+SUHNER Reports Increased Order Intake and Stable Sales Sales Growth Transportation Segment Order Intake Industry Segment Communication Segment
PRESS RELEASE published on 10/22/2024 at 06:45, 1 year 1 month ago HUBER+SUHNER: Higher order intake and stable sales development in first nine months of 2024 HUBER+SUHNER AG reports higher order intake and stable sales development in the first nine months of 2024, with significant growth in the Communication segment Financial Results HUBER+SUHNER AG Order Intake Sales Development Communication Segment
Published on 12/05/2025 at 02:35, 3 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 24 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
